SEC Form 4 · accession 0001567619-18-006951
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Nov 21, 2018
Accepted (ET)
Nov 26, 2018 · 6:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Nov 21, 2018 | A | 103,558 | $104.18 | A | 344,045 | D | |
| ResMed Common StockF2 | Nov 21, 2018 | F | 57,763 | $104.18 | D | 286,282 | D | |
| ResMed Common Stock | holding | — | — | — | 10,340 | I | Lissette and Michael Farrell Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on November 21, 2018, when the compensation committee certified that the performance metrics were met.
- F2Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.